FDA Entry Review in 2025–2026: SERIO+, PREDICT, and What Changes

Introduction

The FDA’s regulatory oversight of imports is constantly evolving, with significant changes on the horizon for 2025-2026. As the volume of food, supplements, cosmetics, and medical devices entering the US continues to grow, the FDA has been developing more sophisticated screening systems to balance safety with efficiency.

SERIO+

and PREDICT represent the next generation of these systems, poised to transform how products gain entry to the US market. For international exporters and US importers alike, understanding these upcoming changes isn’t just helpful—it’s essential for business continuity.

Let’s explore what these systems mean for your import strategy and how to prepare for the shifting landscape. SERIO+

What Is SERIO+?

SERIO+ (Screening and Entry Review Integration Optimization Plus) represents the FDA’s next-generation import screening platform. Building on previous systems, SERIO+ is designed to streamline the entry review process while enhancing the agency’s ability to identify potentially risky shipments.

Goals of SERIO+

✔️ Reducing entry processing times for compliant shipments ✔️ Improving targeting accuracy for potentially non-compliant products ✔️ Creating a more transparent process for importers ✔️ Reducing the paperwork burden on both the FDA and industry

Key Features of SERIO+

Enhanced Data Submission Requirements

SERIO+ will require more comprehensive product data before shipment arrival.

This includes: ✔️ More detailed ingredient information for food and supplements ✔️ Complete manufacturing process documentation ✔️ Enhanced supply chain traceability records ✔️ Prior compliance history While this might seem burdensome, the benefit is that well-prepared companies will see faster clearance times as the system can more confidently assess risk.

Tiered Review Approach

SERIO+ introduces a tiered system that categorizes imports based on risk profiles: ✔️ Tier 1: Expedited review for established importers with excellent compliance history ✔️ Tier 2: Standard review for most products ✔️ Tier 3: Enhanced review for high-risk products or importers with compliance issues Your tier assignment will directly impact clearance times and examination frequency, making a strong FSVP compliance history more valuable than ever.

Integration of Artificial Intelligence

Perhaps the most significant advancement in SERIO+ is its AI component, which: ✔️ Learns from past entry decisions to improve accuracy ✔️ Identifies patterns that human reviewers might miss ✔️ Adapts to emerging risks and trends in real-time This means the system gets smarter with each shipment, potentially reducing false holds while better catching genuinely problematic products.

PREDICT

What Is PREDICT?

PREDICT (Predictive Risk-based Evaluation for Dynamic Import Compliance Targeting) has been the FDA’s risk-based screening tool since 2011. In 2025-2026, PREDICT will undergo significant upgrades to work alongside SERIO+.

Purpose of PREDICT

PREDICT focuses on: ✔️ Assessing the risk level of each import entry ✔️ Determining which shipments need physical examination ✔️ Prioritizing FDA resources toward the highest-risk products ✔️ Facilitating faster clearance of low-risk items

Operating Mechanisms of PREDICT

Machine Learning Algorithms

The updated PREDICT system employs sophisticated algorithms that: ✔️ Analyze hundreds of risk factors simultaneously ✔️ Compare current entries against historical patterns ✔️ Adjust risk scores based on changing conditions ✔️ Factor in information from other regulatory agencies globally For example, if similar products from a particular region have shown contamination issues, your product from that area might receive greater scrutiny—even if your company has a clean record.

Clarity on Required Data for Successful Reviews

The revamped PREDICT system will provide more transparency about: ✔️ What data points influence risk scores ✔️ How documentation gaps affect clearance probability ✔️ Which information can help reduce examination frequency This increased clarity helps importers better prepare submissions and anticipate potential issues before they cause delays.

Anticipated Changes for 2025-2026

Increased Efficiency in Review Processes

The integration of SERIO+ with the upgraded PREDICT system aims to: ✔️ Reduce review times for compliant entries ✔️ Decrease physical inspection rates for companies with strong compliance histories ✔️ Enable 24/7 automated preliminary screening This efficiency gain will be especially beneficial for perishable products where time is critical.

Focus on Transparency and Stakeholder Engagement

The FDA is planning to: ✔️ Launch a new importer portal with real-time status updates ✔️ Provide more detailed reasons for holds or examinations ✔️ Offer pre-submission consultations for complex products ✔️ Create clearer pathways for resolving entry issues These changes reflect the FDA’s recognition that better communication benefits both regulators and industry.

Real-Time Data Utilization

Both systems will increasingly rely on: ✔️ Live updates from global food safety incidents ✔️ Automated cross-checking with other countries’ alerts ✔️ Supply chain disruption information ✔️ Emerging scientific findings about ingredient risks This means staying informed about global food safety trends becomes even more important for importers.

Continuous Monitoring Strategies Post-Approval

The new systems extend beyond initial entry approval to: ✔️ Track product performance in the marketplace ✔️ Monitor consumer complaints related to imports ✔️ Adjust future risk assessments based on post-market performance ✔️ Create “early warning” mechanisms for potential issues A product’s entry history will increasingly influence future import experiences, creating stronger incentives for sustained compliance.

Implications for Stakeholders

Impact on Sponsors and Companies

For food, supplement, and device importers, these changes mean: ✔️ More upfront data preparation will be necessary ✔️ Compliance history will carry greater weight ✔️ Investments in digital documentation systems will pay off ✔️ Building relationships with FDA officials remains valuable Companies with organized, digital record-keeping systems will have a distinct advantage under the new frameworks.

Benefits for Patients and Healthcare Providers

The enhanced systems promise: ✔️ Faster access to legitimate medical devices and supplements ✔️ Reduced risk of contaminated food products ✔️ Better tracking of product origin and composition ✔️ More information available about imported products

Regulatory Compliance Considerations

To thrive under SERIO+ and the updated PREDICT, importers should: ✔️ Update record-keeping systems to match new data requirements ✔️ Ensure supply chain partners understand their documentation roles ✔️ Consider third-party pre-certification programs ✔️ Develop standard operating procedures for import holds ✔️ Train staff on the new systems and requirements Conclusion The FDA’s entry review updates for 2025-2026 represent a significant shift toward smarter, more efficient import screening.

SERIO+ and the enhanced PREDICT system promise faster clearance for compliant companies while maintaining rigorous safety standards through advanced risk analysis. For importers, preparation is key.

The coming changes will reward companies that invest in comprehensive documentation, maintain strong compliance histories, and understand the factors that influence risk assessment. As these systems roll out, expect an adjustment period where both industry and regulators adapt to new processes.

Companies that embrace the changes early and align their import strategies accordingly will gain a competitive advantage in the US market. Ready to prepare your import strategy for the FDA’s new entry review systems? Global Import Agent specializes in helping international food, supplement, and medical device companies navigate FDA compliance changes with confidence.

Our team of FDA regulatory experts can audit your current import documentation, identify potential gaps for FSVP compliance, and develop tailored strategies to minimize clearance delays.

With our deep understanding of FDA import processes and our proven track record of helping hundreds of companies successfully enter the US market, we can position your products for smooth sailing through the new systems.

Contact us today for a complimentary assessment of your import readiness and discover how our FSVP services can protect your business from costly delays at US ports.